SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001144204-19-011666
Filing Date
2019-03-01
Accepted
2019-03-01 17:01:15
Documents
2

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS tv515058-424b3.htm 424B3 168604
2 GRAPHIC lg_outlook-therap.jpg GRAPHIC 39849
  Complete submission text file 0001144204-19-011666.txt   224681
Mailing Address 7 CLARKE DRIVE CRANBURY NJ 08512
Business Address 7 CLARKE DRIVE CRANBURY NJ 08512 6096193990
Outlook Therapeutics, Inc. (Filer) CIK: 0001649989 (see all company filings)

IRS No.: 383982704 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 424B3 | Act: 33 | File No.: 333-209011 | Film No.: 19650425
SIC: 2836 Biological Products, (No Diagnostic Substances)